Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
activist, agenda, appellate, awaiting, BAL, cardiac, CFO, cheaper, CI, coordinating, criterion, CSF, denote, depository, download, DPF, dynamic, electrocardiogram, ensitrelvir, enstirelvir, eradication, Erroneously, Eurasia, extraordinary, FDIC, fit, formula, fundamental, fundraising, futile, futility, gave, hoc, immaterial, Invivyd, landlord, Likewise, macroeconomic, nasopharyngeal, NextGen, NIST, Nsp, obeldesivir, officially, PCR, Pharmacy, premarket, PTAB, purportedly, Qatar, receptive, reoccurrence, repolarization, resilient, resorting, Retail, runway, Schema, seeded, shareholder, Silicon, speculative, sponsorship, Sr, subscription, sunsetting, surpassed, surveyed, thrive, underway, uninterrupted, Unitary, unrestricted, UPC, uphold, Valley, vast, velpatasivir, VP, weekly, Xocova, yearly
Removed:
absence, AG, Aid, allocating, Alnylam, altogether, analyze, analyzing, anemia, antibody, Asia, assembled, AstraZeneca, attachment, authored, backup, belonging, beneficially, bilayer, bind, Biogen, Biopharma, breath, bundled, call, capsid, catalyze, Chiron, circulate, clarity, Codification, cofounded, cold, collateralize, combat, comprise, conservation, constraint, coronaviridae, cough, dddp, ddrp, deteriorate, directed, dollar, dsRNA, East, elderly, Enanta, encased, envelope, enveloped, Epivir, euro, executed, exemption, exert, expedient, fatigue, feel, forecast, fourth, furnishing, genotype, GlaxoSmithKline, glycoprotein, Golgi, heightening, hemolytic, Hoffmann, hybrid, immigration, indefinite, inferred, intention, judgement, kidney, La, makeup, marketability, measuring, messenger, metabolic, Middle, mimic, minimize, mistakenly, month, movement, muscle, nascent, neutralizing, nonstructural, nucleic, nucleocapsid, obesity, OPM, opportunistically, overcome, overwork, partly, pattern, paused, permeation, pound, practical, precautionary, predominant, prevalent, prioritization, prioritized, promised, proportional, protective, provincial, PWERM, quantitation, redeemable, region, reinvestment, Relenza, representing, reversal, Reyataz, RSV, sequelae, serine, shell, Shield, Shire, soliciting, Southeast, spherical, spread, sterling, strain, structurally, subsided, Summer, surface, Sustiva, syncytial, syndrome, synthetic, TCA, template, teratogenicity, termed, threatening, throat, tract, transcribe, transcribed, transferred, transferring, transitional, translated, transmembrane, transport, turnover, Tyzeka, unapproved, unbilled, Valeant, Valtrex, Videx, virally, virion, Weakening, Wellferon, wholesale, worked, Xofluza, Zerit, Zika
Filing tables
Filing exhibits
Related press release
Associated AVIR transcripts
AVIR similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the registration statements (No. 333-249780) on Form S-8 and (No. 333-261344) on Form S-3 of our report dated February 28, 2024, with respect to the consolidated financial statements of Atea Pharmaceuticals, Inc. and subsidiary.
/s/ KPMG LLP
Boston, Massachusetts
February 28, 2024